Table 1.
Demographics and clinical characteristics of enrolled patients
|
Characteristics |
Midazolam+Fentanyl Group 1 (n=10) |
Propofol+Fentanyl Group 2 (n=10) |
|
Age (years) (mean ± SD) |
42.89±7.52 |
42.67±6.65 |
|
BMI (kg/m2) (mean ± SD) |
25.70±2.07 |
26.20±2.04 |
|
Urban/rural areas, n |
5/4 |
4/5 |
|
ASA grade, n (%): |
|
|
|
▪ ASA I |
7 (70%) |
8 (80%) |
|
▪ ASA II |
3 (30%) |
2 (20%) |
|
HP lesions, n (%): |
|
|
|
▪ Endometrial hyperplasia without atypia |
5 (50%) |
6 (60%) |
|
▪ Endometrial hyperplasia with atypia |
4 (40%) |
3 (30%) |
|
▪ Endometrioid endometrial carcinoma |
1 (10%) |
1 (10%) |
ASA: American Society of Anesthesiologists; BMI: Body mass index; HP: Histopathological; n: No. of cases; SD: Standard deviation